Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2019 sales of USD 9.7 billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people’s lives. We’re committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,600 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world.

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. Nephron fills the needs of patients and health care professionals as they arise nationwide, and recently opened a CLIA-certified diagnostics lab that offers COVID-19 tests for people across South Carolina.

SCA Pharma is a nationally recognized FDA 503B outsourcing facility specializing in providing the highest quality sterile admixture services to hospital pharmacies throughout the U.S. Choosing to outsource products with SCA alleviates common problems health care facilities face such as wasted product, drug shortages, time-consuming processes, compliance issues, staffing costs, and patient safety concerns. Our state-of-the-art facilities exceeds USP <797> standards and meets cGMP requirements. Our very talented, experienced, and dedicated team of professionals is committed to providing the safest products for patients and outstanding service. It is our policy to create a partnership with our customers based on values, quality, innovations, and patient safety.

QuVa Pharma is a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. QuVa was purpose-built to change the 503B industry for the better and we are leading the way in making it more safe, efficient, and reliable. With unmatched expertise in cGMPs and sterile pharmaceutical manufacturing, we achieve higher than required quality and safety standards, and maintain a leading FDA compliance record, so hospitals can more reliably focus on patient care. While leading cGMP processes, sterile-to-sterile portfolio, and expansive capacity of ~300,000 sq. ft. across four facilities are our foundation of success, customer-focused service and transparency are how we help hospitals better meet their patient care and operational needs. We are proud to be recognized as the partner of choice for many of the nation’s leading health systems.

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the Autonomous Pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 6,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell’s innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

Kit Check is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking medication intelligence platforms provide item level visibility, workflow simplicity and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 500 U.S. and Canadian hospital partners have tracked more than 100 million medications using Kit Check’s RFID product. Bluesight™ for Controlled Substances software is currently in use in more than 100 hospitals including full health system implementations, with more than 11 million cases tracked, and was ranked #1 in the Drug Diversion Monitoring category in the 2019 Best in KLAS report.

Avery Dennison Corporation (NYSE: AVY) is a global materials science company specializing in the design and manufacture of a wide variety of labeling and functional materials. The company’s products, which are used in nearly every major industry, include pressure-sensitive materials for labels and graphic applications; tapes and other bonding solutions for industrial, medical, and retail applications; tags, labels and embellishments for apparel; and radio frequency identification (RFID) solutions serving retail apparel and other markets. Headquartered in Glendale, California, the company employs more than 32,000 employees in more than 50 countries. Reported sales in 2020 were $7.0 billion.

Identiv is a global leader in seamless authentication and security solutions. We verify frictionless access and anywhere operations, protect identities from malicious attacks, secure intellectual property, and drive IoT innovation. We digitally secure the physical world.

With over 50 years of printing experience and 17 years developing custom RFID applications for the industry, MPI is the leader when it comes to RFID labels and tags. Our experienced and knowledgeable staff guide customers through the entire RFID process and help them determine their needs, from RFID labels and tags to printers, encoding software, readers, and RFID applicators.

CCL Healthcare, a division of CCL Label, is focused on producing secondary packaging within cGMP facilities. We pride ourselves in partnering globally with companies of all sizes and manufacturing our products locally to our partners. That is why we have 33 cGMP facilities worldwide and are growing. With over 65 years of printing experience, CCL Healthcare knows quality matters. That is why we have invested heavily into 100% Vision Inspection Systems and deployed the most rigorous quality assurance process in the industry. What does this mean for our partners? CCL Healthcare is dedicated to providing our partners with the lowest cost of ownership in the industry. CCL Healthcare works with the industry leaders in the development of new RFID tags, inlay sizes, software and systems integrators to ensure the successful launch of your next RFID project. CCL has invested heavily into highly trained personnel and new state of the art equipment. With our skilled staff we are able innovate not only at the product level but at the machinery level modifying equipment to push the boundaries to achieve what was once not possible yesterday to the what is possible today.

In 2003, George Schmitt & Co. became the first company in the world to provide item level pharmaceutical labels with RFID capability. This was accomplished by using Schmitt’s proprietary assembly and testing equipment and processes which ensured 100% readable inlays. Today, George Schmitt enjoys the reputation as the preeminent supplier of the most demanding RFID applications. Schmitt is a valued converter partner to leading inlay manufacturers, system integrators, and end-use customers. Product offerings include RFID pharmaceutical labels, cryogenic laboratory labels, safety product labels, as well as RFID labels across multiple industries ensuring visibility, traceability and reliable complete and accurate data.

Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich, is a leader in the development and manufacture of innovative specialty labels with value-added benefits for the pharmaceutical and medical device industry. The product portfolio includes labels with integrated hangers, with detachable parts and multi-page labels. Additionally, the company offers anti-tampering and counterfeiting protection solutions as well as NFC/RFID labels and smart packaging solutions. These products simplify dispensing and administering of pharmaceuticals, enhance drug safety and clearly reduce process costs. Thanks to its strong solutions expertise and specialized know-how Schreiner MediPharm is a highly capable development partner and quality supplier to leading pharmaceutical companies worldwide. In the field of label-integrated RFID solutions, Schreiner MediPharm cooperates with renowned inlay and technology providers and develops customized antenna and label designs that are optimized for diverse use cases. Unique, highly robust yet flexible RFID-Labels ensure easy integration into the pharma manufacturer’s production and handling processes while providing reliable functionality from production through end use.

SML is a global branding solutions provider and is the parent company of SML RFID. As the leading full-service RFID solution provider, SML is a trusted partner to the world’s largest retailers and top fashion brands, delivering proven results and rapid ROI for our customers. SML offers a broad spectrum of certified RFID-enabled labels, tags, stickers and inlays from the largest global network of source-tagging service bureaus. SML Intelligent Inventory Solution’s Clarity® enterprise-class platform has best-in-class features and functionality for RFID deployment in retail store operations and throughout the retail supply chain.

Tageos is a global market leader in the design and manufacturing of RFID inlays and tags. The company provides a comprehensive portfolio of high-quality, innovative RAIN RFID (UHF), NFC and HF products, enabling customers such as retailers, brand owners and industrial manufacturers to identify, authenticate, track and trace, and complement their product offerings in a wide range of applications and markets. Tageos is ISO 9001-2015 certified and has received ARC Quality Certification from Auburn University’s RFID Lab for the design and manufacturing of its RFID inlays and tags. Tageos is headquartered in Montpellier, France, with offices, sales, R&D and operations in Germany, USA, Hong Kong and China.

For 50 years, International Medical Industries, Inc. has worked closely with pharmacists and compounding professionals to create innovative sterile products that meet very specialized needs. A prime example is the Prep-Lock™ Tamper Evident Syringe Cap technology. The Prep-Lock product family has become the tamper evidence standard among hospital pharmacies and outsource compounders everywhere. IMI remains at the forefront of developing new products specifically designed for the compounding industry. In addition, IMI has established long-standing partnerships with some of the biggest names in health care. Through these partnerships and directly, IMI is delivering the kind of high quality and high-value products that pharmacy operations demand. All IMI products are manufactured in the United States under the strictest quality standards at our FDA-registered, ISO 13485–certified facility.

SCHOTT Pharmaceutical Systems helps people around the world protect, access and use the medicine they need as safely and conveniently as possible. As market leader in primary packaging made of glass and polymer, we are safeguarding and advancing the integrity of injectable solutions and more. We are pioneers with unsurpassed quality, safety and reliability.

With over 30 years’ experience, we are a global provider of label solutions, supporting brands, retailers and manufacturers all around the world. We have an established record of supporting many of the best-known names in our industry with a wide variety of apparel labelling solutions. We also wholly own a widespread amount of printing & encoding operations across a number of key locations across the globe; all of which are connected by our proprietary supply chain application platform, LabelVantage™, to ensure we are here for you, wherever you need us. 360RFID is our latest fully integrated RFID solution that improves item availability through inventory accuracy, customer experience, loss-prevention and offers frictionless checkout. From professional services, variable data printing, RFID tags & inlays to RFID hardware and software, we can support your RFID journey every step of the way.